Scientists try to turn 'Cold' tumors 'Hot' to fight spreading colon cancer
NCT ID NCT05504252
Summary
This study is testing if a standard chemotherapy drug (oxaliplatin) can make advanced colon cancer more visible to the immune system. Researchers then add an immunotherapy drug (nivolumab) to see if this combination can stop the cancer from growing for a longer time. The trial is for 80 adults with a specific type of metastatic colon cancer who haven't had treatment for their spread disease yet. Patients receive cycles of chemo and immunotherapy, with treatment breaks if the cancer shrinks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital
Lørenskog, Akershus, 1478, Norway
-
Oslo University Hospital
Oslo, Akershus, 0424, Norway
-
St Olavs Hospital
Trondheim, Trøndelag, 7006, Norway
Conditions
Explore the condition pages connected to this study.